Invention Application
- Patent Title: Formulations of Enzalutamide
-
Application No.: US18931464Application Date: 2024-10-30
-
Publication No.: US20250049721A1Publication Date: 2025-02-13
- Inventor: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
- Applicant: Astellas Pharma Inc. , Medivation Prostate Therapeutics LLC
- Applicant Address: JP Tokyo; US NY New York
- Assignee: Astellas Pharma Inc.,Medivation Prostate Therapeutics LLC
- Current Assignee: Astellas Pharma Inc.,Medivation Prostate Therapeutics LLC
- Current Assignee Address: JP Tokyo; US NY New York
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/10 ; A61K9/16 ; A61K31/4164 ; A61K31/4166 ; A61K47/32 ; A61K47/38 ; C07D233/86
Abstract:
This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
Information query
